[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613404":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":29,"responsibleParty":49,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":10,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":68,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Biobank Collection Arm",null,"Participants diagnosed with cutaneous melanoma or non-melanoma skin cancer or healthy controls will provide informed consent for collection and long-term storage of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and associated clinical data for future research.",[13],"Other: Collection of Human Body Material and Clinical Data",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Collection of Human Body Material and Clinical Data","Blood sampling (serum, plasma, DNA) Tissue sampling (additional biopsy if consented) Completion of Cancer Worry Scale questionnaire",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Annemiek Leeman, Prof. Dr.","CONTACT","0032 016337950","annemiek.leeman@uzleuven.be",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"Sofie Van Kelst, BSc","0032 016337864","sofie.vankelst@kuleuven.be",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"UZLeuven, Department of Dermatology","RECRUITING","Leuven","Vlaams-Brabant","3000","Belgium","BE",{"type":39,"coordinates":40},"Point",[41,42],4.70093,50.87959,{"lat":42,"lon":41},[45,47],{"name":46,"role":22,"phone":27,"phoneExt":10,"email":28},"Sofie Van Kelst, Bsc",{"name":21,"role":48,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100613404","prospective-collection-of-clinical-data-and-human-body-material-hbm-of-cutaneous-melanoma-non-melanoma-patients-and-healthy-controls-biobank-huidkanker-100613404",false,"NCT07266142","Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker","Prospective Collection of Clinical Data and Human Body Material (HBM): Blood (Serum, Plasma, DNA) and Tissue of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker","Inclusion Criteria:\n\n* Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures\n* Adult subjects (\\>18 years of age) at time of enrolment.\n* Subjects diagnosed with cutaneous melanoma, Non-melanoma skin cancer or healthy controls.\n* Adult subjects able and willing to provide informed consent.\n\nExclusion Criteria:\n\n* Subjects unable or not willing to provide informed consent.\n* Pregnancy (or willing to become pregnant) is NOT an exclusion criteria (unless specified in the respective satellite protocols.","ALL","18 Years",{"count":61,"type":62},7500,"ESTIMATED","OBSERVATIONAL","The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma, non-melanoma skin cancer and healthy controls.\n\nThe main questions it aims to answer are:\n\n* To create a biobank with samples of human body material (HBM): blood (serum\u002Fplasma\u002FDNA) and tissue and clinical data of patients with cutaneous melanoma, non-melanoma and helathy controls.\n* To support future research questions (after specific approval of the Ethics Committee) by using the biobank (through satellite protocols).\n\nIf there is a comparison group: Not applicable (umbrella protocol for collection only).\n\nParticipants will:\n\n* Share demographics, medical and surgical history, risk factors.\n* Complete Cancer Worry Scale questionnaire.\n* Provide biological samples:\n\n  * Blood samples (serum, plasma, DNA).\n  * Tissue samples (residual tissue or additional biopsy if consented).",[66,67],"Skin Cancer, Non-Melanoma","Skin Cancer Melanoma",[69,70,71],"Prospective Collection","Skin Cancer","Human Body Material","2026-06-10",{"date":74,"type":75},"2026-06-12","ACTUAL",{"date":77,"type":75},"2025-11-17",{"date":79,"type":62},"2051-01",{"name":5,"class":6},1]